LFMD LIFEMD INC

LifeMD Executives to Participate in RWJBarnabas Health’s Telehealth Symposium

LifeMD Executives to Participate in RWJBarnabas Health’s Telehealth Symposium

NEW YORK, Dec. 07, 2023 (GLOBE NEWSWIRE) -- ™ (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the RWJBarnabas Health Telehealth Symposium on Thursday, December 14 from 10:00 a.m. – 1:00 p.m. EST. The Symposium, which LifeMD is also sponsoring, will feature experts from RWJBarnabas Health and LifeMD discussing the increasingly important and complex role of telehealth in delivering quality and timely patient care.

Anthony Puopolo, MD, President of LifeMD Affiliated P.C.s, will be serving on a panel addressing the significant value of telehealth expanding and enhancing access to quality healthcare. Eric Yecies, Chief Legal Officer & General Counsel of LifeMD, will also be serving as a panelist, addressing a variety of policy and regulatory considerations related to virtual care. RWJBarnabas Health is the largest and most comprehensive health care system in the state of New Jersey.

“At LifeMD, our entire organization is committed to using telehealth to help Americans get the quality healthcare they need, affordably and conveniently. We are proud to partner and support an organization of the quality and caliber of RWJBarnabas Health as it works to educate its providers on the importance of telemedicine,” said Justin Schreiber, Chairman and CEO, LifeMD.

The sessions include:

Expanding Access to Care: Telehealth (10:15 a.m. – 11:15 a.m. EST)

Panelists:

Neil Palmisiano, MD, Medical Oncology, RWJBarnabas Health

Frank A. Sonnenberg, MD, Internal Medicine, RWJBarnabas Health

Anthony Puopolo, MD, President, LifeMD Affiliated P.C.s

Moderator: Andy Anderson, MD, Chief Medical and Quality Officer, RWJBarnabas Health

Policies, Procedures, Regulations: Telehealth (11:45 a.m. – 12:45 p.m. EST)

Panelists:

Frank A. Sonnenberg, MD, Internal Medicine, RWJBarnabas Health

Eric Yecies, Chief Legal Officer & General Counsel, LifeMD

Moderator: Brian Dobosh, Vice President Digital Health | IT&S, RWJBarnabas Health

To register, simply click .

About LifeMD, Inc.

LifeMD is a leading provider of virtual primary care. LifeMD offers telemedicine, laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s health, women’s health, allergy & asthma, and dermatology. Leveraging a vertically-integrated, proprietary digital care platform, a 50-state affiliated medical group, and a U.S.-based patient care center, LifeMD is elevating healthcare by increasing access to top-notch and affordable care. For more information, please visit .

Company Contact

Marc Benathen, CFO

Media Contact

Jessica Friedeman, Chief Marketing Officer



EN
07/12/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on LIFEMD INC

 PRESS RELEASE

LifeMD to Participate in Two Investor Conferences During March

LifeMD to Participate in Two Investor Conferences During March NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of March: Mizuho Securities Healthcare Technology Conference 2026, March 5. Management will hold virtual one-on-one meetings with investors throughout the day.KeyBanc Capital Markets Healthcare Forum, March 17-18. Management will participate in a virtual fireside chat on Wednesday, March 18th at 9:00 a.m. ...

 PRESS RELEASE

LifeMD to Report Fourth Quarter 2025 Financial Results on March 9

LifeMD to Report Fourth Quarter 2025 Financial Results on March 9 NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on March 9, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Monday, March 9thTime:4:30 p.m. Eastern timeToll-Free Dial-In:800-343-5172International Dial-In:203-518-9856Conference ID:LIFEMDLive & Archiv...

 PRESS RELEASE

LifeMD Announces Closing of $50 Million Revolving Credit Facility with...

LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A. NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, today announced the closing of a new senior secured revolving credit facility (“RCF”) with Citizens Bank, N.A. (“Citizens”). The facility has a maturity date of January 2, 2029 and provides for up to $50 million of total availability consisting of $30 million of committed availability with an additional accordion option of up to $20 million. As of closing, no balance was dra...

 PRESS RELEASE

LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealt...

LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill Adds first and only FDA‑approved oral GLP‑1 to its virtual weight management offering, expanding access to affordable, branded treatment options NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, today announced it is Novo Nordisk’s Wegovy® (semaglutide) pill – the first and only FDA-approved oral GLP-1 therapy for chronic weight management and cardiovascular health – through its end-to-end teleh...

 PRESS RELEASE

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Pr...

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock NEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy solutions, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on January 15, 2026, to holders of record at the close of business on January 5, 2026. About LifeMD, Inc.LifeMD® is a leading provide...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch